ConductScience.org, home

Paper337363

The utility of protected-environment regimens for the compromised host: a critical assessment.

Pizzo PA and 1 other. Prog Hematol, 1977. Cited by 15 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The utility of protected-environment regimens for the compromised host: a critical assessment. Papers, record 337363. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/337363

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The utility of protected-environment regimens for the compromised host: a critical assessment.
PubMed
Journal
Prog Hematol
PubMed
Year
1977
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.79
iCite
Revised in PubMed
2004-11-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pizzo PAP A
2Levine ASA S

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial InfectionsMajor topic
Environment, ControlledMajor topic
NeoplasmsMajor topic
Acute Disease
Anemia, Aplastic
Antibiotics, Antineoplastic
Filtration
Hospital Design and Construction
Humans
Immunologic Deficiency Syndromes
Leukemia
Lymphoma

Source PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
8,739,653Prevention of infection in children with acute leukaemia. No major difference between total and selective bowel decontamination.Support Care Cancer1996https://conductscience.org/library/papers/8739653PubMed
7,726,614A survey of recommendations given to patients going home after bone marrow transplant.Arch Dis Child1994https://conductscience.org/library/papers/7726614PubMed
6,928,791The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia.Blut1980https://conductscience.org/library/papers/6928791PubMed
6,880,186Preventing infection in neutropenic cancer patients.West J Med1983https://conductscience.org/library/papers/6880186PubMed
6,772,872[Hematopoietic stimulation for enhanced bone marrow regeneration after chemotherapy (author's transl)].Klin Wochenschr1980https://conductscience.org/library/papers/6772872PubMed
6,769,945Simple and microbiologically safe portable transport unit for patients requiring protected isolation.J Clin Microbiol1980https://conductscience.org/library/papers/6769945PubMed
98,107Infection in acute leukemia patients receiving oral nonabsorable antibiotics.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/98107PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/337363

GET https://conductscience.org/api/papers/v1/337363/authors